Clinical Trials

Cholesterol drug's safety reconfirmed in analysis of 49 clinical trials, developer reports

Published in Drug Week, February 17th, 2006

Results of a recent analysis of 49 Lipitor clinical trials involving more than 14,000 patients showed that overall rates of treatment-related adverse events reported by patients taking the highest dose of cholesterol drug Lipitor were low and similar to those reported by patients who received placebo or the lowest dose of Lipitor.

The analysis, which was published in the American Journal of Cardiology, included Lipitor clinical trials that were initiated and completed between 1992 and 2004 and tracked the incidence of nonserious and serious muscle, liver and kidney adverse events and laboratory tests. The analysis compared 7,258 patients who received Lipitor 10...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2006-02-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry